维普中文期刊产品整合服务
750篇 您的检索式:作者名="CANNON R"
    题名 作者 年代 出处 被引量
1Blood glucose changes surrounding initiation of tumor-necrosis factor inhibitors and conventional disease-modifying anti-rheumatic drugs in veterans with rheumatoid arthritis显示文摘AIM To determine the scope of acute hypoglycemic effects for certain anti-rheumatic medications in a large retrospective observational study. METHODS Patients enrolled in the Veterans Affairs Rheumatoid Arthritis (VARA) registry were selected who, during follow-up, initiated treatment with tumor necrosis factor inhibitors (TNFi's, including etanercept, adalimumab, infliximab, golimumab, or certolizumab), prednisone, or conventional disease-modifying anti-rheumatic drugs(DMARDs), and for whom proximate random blood glucose (RBG) measurements were available within a window 2-wk prior to, and 6 mo following, medication initiation. Similar data were obtained for patients with proximate values available for glycosylated hemoglobin A1C values within a window 2 mo preceding, and 12 mo following, medication initiation. RBG and A1C measurements were compared before and after initiation events using paired t-tests, and multivariate regression analysis was performed including established comorbidities and demographics.RESULTS Two thousands one hundred and eleven patients contributed at least one proximate measurement surrounding the initiation of any examined medication. A significant decrease in RBG was noted surrounding 653 individual hydroxychloroquine-initiation events(-3.68 mg/dL, P = 0.04), while an increase was noted for RBG surrounding 665 prednisone-initiation events(+5.85 mg/d L, P < 0.01). A statistically significant decrease in A1C was noted for sulfasalazine initiation, as measured by 49 individual initiation events(-0.70%, P < 0.01). Multivariate regression analyses, using methotrexate as the referent, suggest sulfasalazine (β =-0.58, P = 0.01) and hydroxychloroquine(β =-5.78, P = 0.01) use as predictors of lower post-medicationinitiation RBG and A1C values, respectively. Analysis by drug class suggested prednisone (or glucocorticoids) as predictive of higher medication-initiation event RBG among all start events as compared to DMARDs, while this analysis did not show any drug class-level effect for TNFi. A diagnosis of congestive heart failure(β = 4.69, P = 0.03) was predictive for higher post-initiation RBG values among all medication-initiation events.CONCLUSION No statistically significant hypoglycemic effects surrounding TNFi initiation were observed in this large cohort. Sulfasalazine and hydroxychloroquine may have epidemiologically significant acute hypoglycemic effects.Patrick R Wood Evan Manning Joshua F Baker Bryant England Lisa Davis Grant W Cannon Ted R Mikuls Liron Caplan 2018World Journal of Diabetes2018,9,2:8
2Peripherally administered antibodies against amyloid β-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer ' s disease显示文摘Bard F Cannon C Barbour R 2000Nat Med2000,6,8:2
3Ridging effects on metting and spreading of liquids on solids显示文摘Saiz E Tomsin A P Cannon R M 1998Acta Mater1998,46,7:2
4Tree species diversity in commercially logged Bornean rainforest 显示文摘Cannon C H Peart D R Leighton M 1998Science1998,281,:1
5Efficient implementation of the fuzzy c-means clustering algorithm显示文摘Cannon R L Dave J Bezdek J C 1986IEEE Transactions on Pattern Analysis and Machine Intelligence1986,8,2:1
6Daily catheter-direct-ed single dosing of t-PA in treatment of acute deep venous thrombosis of the lower extremity显示文摘Chang R Cannon RO Chen CC 2001J Vasc Interv Radiol2001,12,:1
7Bt transgenic crops: risks and benefits 显示文摘Cannon R J C 2000Integrated Pest Management Reviews2000,5,3:1
8Stress and decohesion of oxide scales显示文摘EVANS A G CANNON R M 1989Materials Science Forum1989,43,3:1
9Non-classical H^1-projection and Galerkin methods for nonlinear parabolic integrodifferential equations显示文摘Cannon J R Lin Y 1988Calcolo1988,25,3:1
10Prognostic utility of apoB/Al, total cholesterol/HDL, non-HDL cholesterol, or hs-CRP as predictors of clinical risk in patients receiving statin therapy after acute coro- nary syndromes:results from PROVE IT-TIMI 22 显示文摘Ray KK Cannon CP Cairns R 2009Arterioscler Thromb Vasc Biol2009,29,3:1
11Classification and nomenclature of viruses of cyanobacteria显示文摘Safferman R S Cannon R E Desjardins P R 1983Intervirology1983,19,2:1
12Candida albicans: adherence, signaling and virulence 显示文摘Calderone R Suzuki S Cannon R 2000Med Mycol2000,38,1:1
13Epitope and isotype specificities of antibodies to beta -amyloid peptide for protection against Alzheimer' s disease-like neuropathology显示文摘Bard F Barbour R Cannon C 2003Proc Natl Acad Sci USA2003,100,4:1
14Finite element analysis of the effects of corners on residual stres?ses in protective oxide scales显示文摘WRIGHTJ K WILLIAMSON R L CANNON R M 1997Mat Sci Eng (A)1997,230,:1
15Sulfate anion in water:model structural,thermodynamic,and dynamic properties显示文摘Cannon W R Pettitt B M McCammont J A 1994Journal of Physical Chemistry1994,98,24:1
16Surgical resection for hilar cholangiocarcinoma: experience improves resectability 显示文摘Cannon R M Brock G Buell J F 2012HPB (Oxford)2012,14,2:1
17Prognostie utility of ApoB/AI, total chole- sterol/HDL, non- HDL cholesterol, or hs- CRP as predictors of clinical risk in patients receiving sta- tin therapy after acute coronary syndromes: results from PROVE IT-TIMI 22 显示文摘RAY K K CANNON C P CAIRNS R 2009Arterioscler Thromb Vase Biol2009,29,3:1
18Peripherally administered antibodies against amyloid β-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer's disease 显示文摘Bard F Cannon C Barbour R 2000Nature Medicine2000,6,8:1
19Aging and stress-induced changes in complement activation and neutrophil mobilization显示文摘Cannon J G Fiatarone M A Fielding R A 1994J Appl Physiol1994,76,6:1
20Relationship between un- controlled risk factors and C-reactive protein levels in patients re- ceiving standard or intensive statin therapy for acute coronary syn- dromes in the PROVE IT-TIMI 22 trial显示文摘Ray KK Cannon CP Cairns R 2005J Am Coil Cmdiol2005,46,8:1
返回顶部 每页显示:
共38页 首页 上一页 第1页 下一页 末页 /38 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费